AstraZeneca Reports Positive Results in Late-Stage Trials for Brilinta, FarxigaAnalysts, Atherothrombotic Events, Cardiovascular (CV) Death, Clinical Data, Clinical Trials, Coronary Artery Disease (CAD), Heart Attacks, Investors, R&D, Strokes, Type 2 DiabetesAstraZeneca reported positive results from clinical trial programs for Brilinta and Farxiga, causing stock to jump 3.4 percent. Read more September 3, 2019/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png 0 0 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2019-09-03 12:37:162019-09-03 15:01:43AstraZeneca Reports Positive Results in Late-Stage Trials for Brilinta, Farxiga
